Pharma Aids (DHA:PHARMAID) E10: BDT-36.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:PHARMAID Pharma Aids Ltd DHA:PHARMAID
73 GF Score
Price BDT644.70
GF Value BDT758.56
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Aids E10?

Pharma Aids DHA:PHARMAID -2.55% 73 E10 is BDT-36.77 as of Mar. 2026. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharma Aids's adjusted earnings per share data for the three months ended in Mar. 2026 was BDT611.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is BDT-36.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Aids's average E10 Growth Rate was -162.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-17), Pharma Aids's current stock price is BDT644.70. Pharma Aids's E10 for the quarter that ended in Mar. 2026 was BDT-36.77. Pharma Aids's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Pharma Aids was 72.17. The lowest was 7.80. And the median was 60.52.


Pharma Aids  (DHA:PHARMAID) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Pharma Aids was 72.17. The lowest was 7.80. And the median was 60.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pharma Aids E10 Related Terms


Pharma Aids E10 Historical Data

* Premium members only.

The historical data trend for Pharma Aids's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Aids E10 Chart

Pharma Aids Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 12.93 12.51 14.12 -96.22

Pharma Aids Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.13 -96.22 -96.42 -95.81 -36.77

DHA:PHARMAID vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Pharma Aids's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Aids Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Aids's Shiller PE Ratio falls into.


DHA:PHARMAID
73GF Score
Pharma Aids Ltd DHA:PHARMAID
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Aids E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Aids's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=611/330.2130*330.2130
=611.000

Current CPI (Mar. 2026) = 330.2130.

Pharma Aids Quarterly Data

per share eps CPI Adj_EPS
201606 1.800 241.018 2.466
201609 2.000 241.428 2.735
201612 2.900 241.432 3.966
201703 2.270 243.801 3.075
201706 2.303 244.955 3.105
201709 3.800 246.819 5.084
201712 4.260 246.524 5.706
201803 4.290 249.554 5.677
201806 2.725 251.989 3.571
201809 4.630 252.439 6.056
201812 4.670 251.233 6.138
201903 4.150 254.202 5.391
201906 2.020 256.143 2.604
201909 4.630 256.759 5.955
201912 5.150 256.974 6.618
202003 4.340 258.115 5.552
202006 2.510 257.797 3.215
202009 4.010 260.280 5.087
202012 4.030 260.474 5.109
202103 4.120 264.877 5.136
202106 3.936 271.696 4.784
202109 5.150 274.310 6.200
202112 5.530 278.802 6.550
202203 4.630 287.504 5.318
202206 -4.171 296.311 -4.648
202209 1.990 296.808 2.214
202212 -0.760 296.797 -0.846
202303 -1.210 301.836 -1.324
202306 -2.100 305.109 -2.273
202309 3.680 307.789 3.948
202312 7.210 306.746 7.762
202403 7.460 312.332 7.887
202406 1.240 314.175 1.303
202409 5.660 315.301 5.928
202412 5.660 315.605 5.922
202503 445.000 319.799 459.491
202506 -1,556.550 322.561 -1,593.475
202509 6.810 324.800 6.923
202512 7.280 324.054 7.418
202603 611.000 330.213 611.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of BDT-36.77 mean?
Pharma Aids (DHA:PHARMAID) has a E10 of BDT-36.77 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharma Aids and its competitors.
Is Pharma Aids' E10 too high?
Pharma Aids' current E10 is BDT-36.77. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' E10 compare to ISRG and BDX?
Pharma Aids' E10 of BDT-36.77 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharma Aids and its competitors. Pharma Aids's current E10 is BDT-36.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current E10 is BDT-36.77. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current E10 is BDT-36.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued. The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56. GuruFocus considers Pharma Aids to be Modestly Undervalued.

Key valuation signals for DHA:PHARMAID:

  • E10: BDT-36.77
  • GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Aids Business Description

Address 345 Segun Bagicha, 1st Floor, Ramna, Dhaka, BGD, 1000
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score

Get the complete analysis for DHA:PHARMAID

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT644.70
Price
BDT758.56
GF Value